United States Thyroid Gland Disorders Treatment Market Report & Forecast 2021-2027

Publisher Name :
Date: 15-Oct-2021
No. of pages: 90
Inquire Before Buying

United States Thyroid Gland Disorders Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Thyroid Gland Disorders Treatment Market Segment Percentages, By Type, 2020 (%)

- Hypothyroidism

- Hyperthyroidism

United States Thyroid Gland Disorders Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Thyroid Gland Disorders Treatment Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Clinics

- Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thyroid Gland Disorders Treatment revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Thyroid Gland Disorders Treatment revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- AbbVie

- Merck KGaA

- Lannett Company

- Mylan

- Allergan

- Pfizer

- Novartis

- GlaxoSmithKline

- Abbott Laboratories

- Sanofi

United States Thyroid Gland Disorders Treatment Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Thyroid Gland Disorders Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Thyroid Gland Disorders Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Thyroid Gland Disorders Treatment Overall Market Size
2.1 United States Thyroid Gland Disorders Treatment Market Size: 2021 VS 2027
2.2 United States Thyroid Gland Disorders Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Thyroid Gland Disorders Treatment Players in United States Market
3.2 Top United States Thyroid Gland Disorders Treatment Companies Ranked by Revenue
3.3 United States Thyroid Gland Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Thyroid Gland Disorders Treatment Companies in United States Market, by Revenue in 2020
3.5 Companies Thyroid Gland Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Players in United States Market
3.6.1 List of Tier 1 Thyroid Gland Disorders Treatment Companies in United States
3.6.2 List of Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Thyroid Gland Disorders Treatment Market Size Markets, 2021 & 2027
4.1.2 Hypothyroidism
4.1.3 Hyperthyroidism
4.2 By Type - United States Thyroid Gland Disorders Treatment Revenue & Forecasts
4.2.1 By Type - United States Thyroid Gland Disorders Treatment Revenue, 2016-2021
4.2.2 By Type - United States Thyroid Gland Disorders Treatment Revenue, 2022-2027
4.2.3 By Type - United States Thyroid Gland Disorders Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Thyroid Gland Disorders Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - United States Thyroid Gland Disorders Treatment Revenue & Forecasts
5.2.1 By Application - United States Thyroid Gland Disorders Treatment Revenue, 2016-2021
5.2.2 By Application - United States Thyroid Gland Disorders Treatment Revenue, 2022-2027
5.2.3 By Application - United States Thyroid Gland Disorders Treatment Revenue Market Share, 2016-2027
6 Thyroid Gland Disorders Treatment Companies Profiles
6.1 AbbVie
6.1.1 AbbVie Company Details
6.1.2 AbbVie Business Overview
6.1.3 AbbVie Thyroid Gland Disorders Treatment Introduction
6.1.4 AbbVie Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.1.5 AbbVie Recent Developments
6.2 Merck KGaA
6.2.1 Merck KGaA Company Details
6.2.2 Merck KGaA Business Overview
6.2.3 Merck KGaA Thyroid Gland Disorders Treatment Introduction
6.2.4 Merck KGaA Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.2.5 Merck KGaA Recent Developments
6.3 Lannett Company
6.3.1 Lannett Company Company Details
6.3.2 Lannett Company Business Overview
6.3.3 Lannett Company Thyroid Gland Disorders Treatment Introduction
6.3.4 Lannett Company Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.3.5 Lannett Company Recent Developments
6.4 Mylan
6.4.1 Mylan Company Details
6.4.2 Mylan Business Overview
6.4.3 Mylan Thyroid Gland Disorders Treatment Introduction
6.4.4 Mylan Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.4.5 Mylan Recent Developments
6.5 Allergan
6.5.1 Allergan Company Details
6.5.2 Allergan Business Overview
6.5.3 Allergan Thyroid Gland Disorders Treatment Introduction
6.5.4 Allergan Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.5.5 Allergan Recent Developments
6.6 Pfizer
6.6.1 Pfizer Company Details
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Thyroid Gland Disorders Treatment Introduction
6.6.4 Pfizer Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.6.5 Pfizer Recent Developments
6.7 Novartis
6.7.1 Novartis Company Details
6.7.2 Novartis Business Overview
6.7.3 Novartis Thyroid Gland Disorders Treatment Introduction
6.7.4 Novartis Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.7.5 Novartis Recent Developments
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Details
6.8.2 GlaxoSmithKline Business Overview
6.8.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Introduction
6.8.4 GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.8.5 GlaxoSmithKline Recent Developments
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Company Details
6.9.2 Abbott Laboratories Business Overview
6.9.3 Abbott Laboratories Thyroid Gland Disorders Treatment Introduction
6.9.4 Abbott Laboratories Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.9.5 Abbott Laboratories Recent Developments
6.10 Sanofi
6.10.1 Sanofi Company Details
6.10.2 Sanofi Business Overview
6.10.3 Sanofi Thyroid Gland Disorders Treatment Introduction
6.10.4 Sanofi Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021)
6.10.5 Sanofi Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Thyroid Gland Disorders Treatment Market Opportunities & Trends in United States Market
Table 2. Thyroid Gland Disorders Treatment Market Drivers in United States Market
Table 3. Thyroid Gland Disorders Treatment Market Restraints in United States Market
Table 4. Key Players of Thyroid Gland Disorders Treatment in United States Market
Table 5. Top Thyroid Gland Disorders Treatment Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Thyroid Gland Disorders Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Thyroid Gland Disorders Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Thyroid Gland Disorders Treatment Product Type
Table 9. List of Tier 1 Thyroid Gland Disorders Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Thyroid Gland Disorders Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Thyroid Gland Disorders Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Thyroid Gland Disorders Treatment Revenue (US$, Mn), 2022-2027
Table 17. AbbVie Company Details
Table 18. AbbVie Business Overview
Table 19. AbbVie Thyroid Gland Disorders Treatment Product
Table 20. AbbVie Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. AbbVie Recent Developments
Table 22. Merck KGaA Company Details
Table 23. Merck KGaA Business Overview
Table 24. Merck KGaA Thyroid Gland Disorders Treatment Product
Table 25. Merck KGaA Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Merck KGaA Recent Developments
Table 27. Lannett Company Company Details
Table 28. Lannett Company Business Overview
Table 29. Lannett Company Thyroid Gland Disorders Treatment Product
Table 30. Lannett Company Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Lannett Company Recent Developments
Table 32. Mylan Company Details
Table 33. Mylan Business Overview
Table 34. Mylan Thyroid Gland Disorders Treatment Product
Table 35. Mylan Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Mylan Recent Developments
Table 37. Allergan Company Details
Table 38. Allergan Business Overview
Table 39. Allergan Thyroid Gland Disorders Treatment Product
Table 40. Allergan Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Allergan Recent Developments
Table 42. Pfizer Company Details
Table 43. Pfizer Business Overview
Table 44. Pfizer Thyroid Gland Disorders Treatment Product
Table 45. Pfizer Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Pfizer Recent Developments
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Thyroid Gland Disorders Treatment Product
Table 50. Novartis Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novartis Recent Developments
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Thyroid Gland Disorders Treatment Product
Table 55. GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. GlaxoSmithKline Recent Developments
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Thyroid Gland Disorders Treatment Product
Table 60. Abbott Laboratories Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Abbott Laboratories Recent Developments
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Thyroid Gland Disorders Treatment Product
Table 65. Sanofi Thyroid Gland Disorders Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Developments
List of Figures
Figure 1. Thyroid Gland Disorders Treatment Segment by Type
Figure 2. Thyroid Gland Disorders Treatment Segment by Application
Figure 3. United States Thyroid Gland Disorders Treatment Market Overview: 2020
Figure 4. United States Thyroid Gland Disorders Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Thyroid Gland Disorders Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Thyroid Gland Disorders Treatment Revenue in 2020
Figure 7. By Type - United States Thyroid Gland Disorders Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - United States Thyroid Gland Disorders Treatment Revenue Market Share, 2016-2027
Figure 9. AbbVie Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Merck KGaA Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Lannett Company Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Mylan Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Allergan Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Pfizer Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novartis Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Abbott Laboratories Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Sanofi Thyroid Gland Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Thyroid Gland Disorders Treatment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
  • Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
  • Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
  • Global Enzyme Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
  • Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84
    According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
  • Global Hormone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
  • Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs